More reads
- Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France. (STAT)
- Cabaret Biotech files lawsuit against Gilead over Yescarta drug. (Bloomberg Law)
- Genetically modified mosquitoes are breeding in Brazil, despite biotech firm's assurances to the contrary. (Gizmodo)
- Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes. (STAT Plus)
No hay comentarios:
Publicar un comentario